Search research articles
Contact Us
Filters
Showing results (161-170 of 216) with videos related to
Page
of 22
Sort By:
Annals of Surgical Oncology
|
April 10, 2022
The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
Michael P Flood, Joseph C H Kong, Kasmira Wilson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 11, 2012
Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity
Charles H C Pilgrim, Laveniya Satgunaseelan, Alan Pham, et al.
BMC Cancer
|
July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
Trevor Leong, B Mark Smithers, Michael Michael, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series
Isaac Goncalves, Kate Burbury, Michael Michael, et al.
JMIR Research Protocols
|
December 4, 2019
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention
Lisa Guccione, Karla Gough, Allison Drosdowsky, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 18, 2011
mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury
Charles H C Pilgrim, Kate Brettingham-Moore, Alan Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
Oliver Klein, Damien Kee, Ben Markman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience
Raghava Kashyap, Ramin Alipour, Emma Boehm, et al.
Clinical and Translational Science
|
October 25, 2023
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
Sarah Glewis, Mei Krishnasamy, Senthil Lingaratnam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
Jordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 216) with videos related to
Sort By:
Page
of 22
Annals of Surgical Oncology
|
April 10, 2022
The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
Michael P Flood, Joseph C H Kong, Kasmira Wilson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 11, 2012
Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity
Charles H C Pilgrim, Laveniya Satgunaseelan, Alan Pham, et al.
BMC Cancer
|
July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
Trevor Leong, B Mark Smithers, Michael Michael, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series
Isaac Goncalves, Kate Burbury, Michael Michael, et al.
JMIR Research Protocols
|
December 4, 2019
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention
Lisa Guccione, Karla Gough, Allison Drosdowsky, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
October 18, 2011
mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury
Charles H C Pilgrim, Kate Brettingham-Moore, Alan Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
Oliver Klein, Damien Kee, Ben Markman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience
Raghava Kashyap, Ramin Alipour, Emma Boehm, et al.
Clinical and Translational Science
|
October 25, 2023
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
Sarah Glewis, Mei Krishnasamy, Senthil Lingaratnam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
Jordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Page
of 22